Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Acorda Therapeutics (ACOR)

0.6951   -0.018 (-2.54%) 11-27 12:39
Open: 0.72 Pre. Close: 0.7132
High: 0.7202 Low: 0.691
Volume: 1,642,051 Market Cap: 33M
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Selincro, an orally administered drug for the treatment of alcohol dependence in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops Inbrija for the treatment of OFF periods in Parkinson's disease and ARCUS product for the treatment of acute migraine. Further, it develops rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa that is in Phase Ib clinical trial for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and is headquartered in Ardsley, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.762 - 0.766 0.766 - 0.77
Low: 0.688 - 0.693 0.693 - 0.698
Close: 0.702 - 0.71 0.71 - 0.717

Technical analysis

as of: 2020-11-27 12:15:44 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.12     One year: 1.33
Support: Support1: 0.67    Support2: 0.56
Resistance: Resistance1: 0.96    Resistance2: 1.14
Pivot: 0.77
Moving Average: MA(5): 0.71     MA(20): 0.82
MA(100): 0.69     MA(250): 1.07
MACD: MACD(12,26): -0.02     Signal(9):
Stochastic oscillator: %K(14,3): 17.34     %D(3): 13.94
RSI: RSI(14): 42.18
52-week: High: 2.78  Low: 0.42  Change(%): -56.7
Average Vol(K): 3-Month: 644204  10-Days: 242063

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ACOR has closed above bottom band by 14.9%. Bollinger Bands are 17% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 26 Nov 2020
What investors think about Acorda Therapeutics $ACOR from here - Stock Traders Daily

Wed, 25 Nov 2020
Why Acorda Therapeutics Inc. (ACOR)'s Most Recent Report Reveals Some Hints About Its Future | News Heater - The News Heater

Wed, 25 Nov 2020
Acorda Therapeutics Inc. (ACOR) market price of $0.74 offers the impression of an exciting value play - The InvestChronicle

Fri, 20 Nov 2020
H.C. Wainwright slashes price target on Acorda Therapeutics Inc. [ACOR] – find out why. - The DBT News

Fri, 20 Nov 2020
Can Acorda Therapeutics Inc. (ACOR) Remain Competitive? | News Heater - The News Heater

Thu, 05 Nov 2020
Acorda Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Nasdaq

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 48
Shares Float (M) 43
% Held by Insiders 1.69
% Held by Institutions 55.80
Shares Short (K) 7,240
Shares Short P. Month (K) 12,600

Stock Financials

EPS 1.022
EPS Est This Year 1.750
EPS Est Next Year 0.700
Book Value (p.s.) 6.570
Profit Margin 29.71
Operating Margin -49.02
Return on Assets (ttm) -6.4
Return on Equity (ttm) 16.5
Qtrly Rev. Growth 11.2
Gross Profit (p.s.) 3.285
Sales Per Share 3.447
EBITDA (p.s.) -0.852
Qtrly Earnings Growth
Operating Cash Flow (M) -74
Levered Free Cash Flow (M) -69

Stock Valuations

PE Ratio 0.68
PEG Ratio
Price to Book value 0.11
Price to Sales 0.20
Price to Cash Flow -0.45

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.